CD5 and B-cell chronic lymphocytic leukemia: Flow cytometric analyses of peripheral blood cells were performed at 4‐week intervals to monitor the development of B220low CD5+ IgM+ CLL‐like cells, up until 60 weeks of age (Fig 1).